|Bid||110.10 x 100|
|Ask||123.50 x 100|
|Day's Range||110.65 - 115.48|
|52 Week Range||83.01 - 153.15|
|PE Ratio (TTM)||-139.96|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Why small-cap biotechs Celldex Therapeutics, Idera Pharmaceuticals, and NewLink Genetics could be big winners.
Eli Lilly and Company (LLY) and partner Incyte announced that baricitinib met its primary endpoint in a phase II study in people with moderate-to-severe atopic dermatitis.